Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1993-3-22
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0959-8049
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
29A
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
652-3
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8435227-Humans,
pubmed-meshheading:8435227-Immunohistochemistry,
pubmed-meshheading:8435227-Melanoma,
pubmed-meshheading:8435227-Precancerous Conditions,
pubmed-meshheading:8435227-Skin Neoplasms,
pubmed-meshheading:8435227-Tumor Markers, Biological,
pubmed-meshheading:8435227-Tumor Suppressor Protein p53
|
pubmed:year |
1993
|
pubmed:articleTitle |
P53 immunostaining in melanocytic lesions.
|
pubmed:publicationType |
Letter
|